You are here

Ido Amit

Combat team: A dendritic cell (right) and a T cell, both from a mouse with skin cancer, combined using the BiCE antibody (yellow)
18.01.2024

A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...

Decades-Old Mystery of Red Blood Cell Production Finally Solved
27.04.2023

Identifying the cells producing the hormone EPO may lead to the development of new therapies for treating anemia resulting from kidney disease and...

(l-r) Profs. Chamutal Gur and Ido Amit
04.04.2022

Weizmann Institute of Science researchers, in collaboration with Hadassah and Rambam physicians, present a new roadmap for exploring poorly...

multiple myeloma drug resistant cells
22.02.2021

From bedside to bench and back: Researchers reveal a genetic signature that could help overcome drug resistance in some of the most aggressive...

Sharing Science
27.11.2020

A postdoc talks about complicated research, living at the Institute and the joys of scientific outreach

Surprising Players in Acute Liver Failure Point to Potential Treatment
26.10.2020

Gut microbes and host cells jointly contribute to the progression of this mostly incurable disease

pregnant belly with mask on
30.07.2020

In a study in mice, the mother’s natural anti-viral proteins disrupted the development of neural circuits in the fetus

Tissue sample from triple-negative breast cancer, stained for the presence of cancer cells (red) and the two types of cancer-associated fibroblasts: pCAFs (magenta) and sCAFs (green). The nuclei of all cells are stained blue
23.07.2020

Supporting actors in cancer growth may help predict the course of the disease

Prof. Ido Amit
16.06.2020

Prof. Ido Amit is the recipient of the Michael Bruno Memorial Award from the Israel Institute for Advanced Studies at the Hebrew University of...

Prof. Ido Amit
15.12.2019

Prof. Ido Amit is the recipient of the Sanofi – Institut Pasteur 2019 Junior Award

Pages